Definitive Healthcare Corp. (DH)
NASDAQHealth CareMedical - Healthcare Information ServicesSnapshot 2026-09-04
$1.05+0.96%
Close 2026-09-04 · 1-day change
NASDAQHealth CareMedical - Healthcare Information ServicesSnapshot 2026-09-04
Intact: The reason to own it still holds.
Definitive Healthcare aims for $220M to $226M revenue in 2026. It targets $23M to $27M adjusted net income. The company has beaten earnings recently. Its valuation is very low compared to peers.
Revenue is falling from $239M in 2025 to $220M in 2026. Net income remains negative despite guidance. The stock is under pressure and faces delisting risk.
The market expects about 5% revenue decline next year. Our fair value is near $2.83, reflecting this weak outlook. We see limited upside given ongoing losses and weak growth.
Breaks if: adjusted net income remains negative in FY26
Breaks if: revenue falls below $220 million in FY26
Breaks if: PE ratio rises above 10 without earnings improvement
This is not a price target or investment advice.
A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.
This investment represents a turnaround story with a focus on improving revenue and profitability. The current thesis state is cautious, as recent financial performance has been weak and management is under pressure to deliver results.
The market appears to have priced in a low expectation for performance, as indicated by a valuation that is cheap compared to peers. However, there is a notable expectations gap, suggesting that the market is not anticipating significant improvement in the near term.
Fundamentals are likely to show continued struggles in revenue growth, as recent quarters have seen declines. Management has set priorities for improving profitability, but the path to achieving sustained growth remains uncertain.
The thesis hinges on key factors such as management's ability to meet guidance and the overall health of the healthcare sector. Additionally, external economic indicators, like the jobs report, could impact sentiment and performance.
The most important moves since the prior daily snapshot.
Yes, our read has strengthened. The company reported a revenue beat for Q2 2026. It also received a buyout offer from Advent International. This proposal shows strong market interest and potential growth. There are no new threats to the thesis.
as of 2026-09-04
Review the evidence to watch, what would become a concern, and what would make it less concerning.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Over the next 1 to 3 years, DH faces significant challenges but has potential if management can execute its priorities effectively. Not investment advice.